nasuspharma.com - NSRX Sales Growth YoY (TTM)

Graphic logo of nasuspharma.com (NSRX)

Nasus Pharma Ltd (NSRX) develops advanced intranasal powder drug delivery systems to combat viruses. The percentage change in sales over the last 12 months compared to the previous 12 months reflects revenue dynamics, where the value of 0.00 corresponds to the current metric. Nasus Pharma Ltd (NSRX) is expanding its line of emergency therapy drugs, replacing standard treatment methods. Operational processes rely on third-party contractors for manufacturing and global logistics.

Revenue Growth YoY (Last 12 Months): Nasus Pharma Ltd (NSRX) for 11/23/2025 - 11/18/2026

Nasus Pharma Ltd (NSRX) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Summary company analytics:NSRX (Nasus Pharma)
Finished products of Nasus Pharma, Ltd.

This indicator measures the revenue growth rate over the last 12 months relative to the same period last year. By analyzing year-over-year sales volatility over a rolling 12-month period, an investor assesses the business scaling dynamics. For Nasus Pharma Ltd (NSRX), this trend reflects the effectiveness of Taffix commercialization and the implementation of nasal technologies. The upward curve confirms market adoption of innovative drugs. A steady acceleration of this metric indicates high fundamental resilience of the asset.